Methylprednisolone Acetate Injection shortage
Current 23 presentations · 5 manufacturers · first FDA posting 2021-12-15 · last update 2026-10-15
Manufacturers: Amneal Pharmaceuticals, Eugia US LLC, Par Health, USA LLC, Pfizer Inc., Sagent Pharmaceuticals
Stated reasons (per FDA): Demand increase for the drug; Other; Shortage of an active ingredient
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-1) | Amneal Pharmaceuticals | Current Limited Availability |
Other | Estimated recovery: late October 2026/November 2026 | Posted 12/15/2021 Updated 10/06/2026 |
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-5) | Amneal Pharmaceuticals | Current Available |
— | Posted 12/15/2021 Updated 10/06/2026 | |
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-1) | Amneal Pharmaceuticals | Current Available |
— | Posted 12/15/2021 Updated 10/06/2026 | |
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-5) | Amneal Pharmaceuticals | Current Available |
— | Posted 12/15/2021 Updated 10/06/2026 | |
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 55150-313-01) | Eugia US LLC | Current Unavailable |
Demand increase for the drug | On backorder. Recovery: TBD. Check wholesalers for inventory | Posted 12/15/2021 Updated 10/02/2026 |
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 55150-314-01) | Eugia US LLC | Current Unavailable |
Demand increase for the drug | On backorder. Recovery: TBD. Check wholesalers for inventory | Posted 12/15/2021 Updated 10/02/2026 |
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01) | Par Health, USA LLC | Current Unavailable |
Other | Estimated recovery: TBD | Posted 06/16/2022 Updated 10/15/2026 |
| Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01) | Pfizer Inc. | Current Available |
— | Posted 12/15/2021 Updated 09/21/2026 | |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02) | Pfizer Inc. | Current Available |
— | Posted 12/15/2021 Updated 09/21/2026 | |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03) | Pfizer Inc. | Current Limited Availability |
Other | Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Posted 12/15/2021 Updated 09/21/2026 |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51) | Pfizer Inc. | Current Available |
— | Posted 12/15/2021 Updated 09/21/2026 | |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52) | Pfizer Inc. | Current Available |
— | Posted 12/15/2021 Updated 09/21/2026 | |
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02) | Pfizer Inc. | Current Available |
— | Posted 12/15/2021 Updated 09/21/2026 | |
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12) | Pfizer Inc. | Current Available |
— | Posted 12/15/2021 Updated 09/21/2026 | |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01) | Pfizer Inc. | Current Limited Availability |
Demand increase for the drug | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026 | Posted 12/15/2021 Updated 09/21/2026 |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03) | Pfizer Inc. | Current Limited Availability |
Other | Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Posted 12/15/2021 Updated 09/21/2026 |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22) | Pfizer Inc. | Current Unavailable |
Demand increase for the drug | Next Delivery: October 2026; Estimated Recovery: December 2026 | Posted 12/15/2021 Updated 09/21/2026 |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23) | Pfizer Inc. | Current Unavailable |
Other | Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Posted 12/15/2021 Updated 09/21/2026 |
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01) | Pfizer Inc. | Current Limited Availability |
Demand increase for the drug | Limited Supply Available. Next Delivery and Estimated Recovery: December 2026 | Posted 12/15/2021 Updated 09/21/2026 |
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03) | Pfizer Inc. | Current Limited Availability |
Other | Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Posted 12/15/2021 Updated 09/21/2026 |
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-05) | Sagent Pharmaceuticals | Current Available |
Shortage of an active ingredient | Posted 12/15/2021 Updated 10/08/2026 | |
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10) | Sagent Pharmaceuticals | Current Limited Availability |
Shortage of an active ingredient | Limited product available. Estimated recovery: October 2026 | Posted 12/15/2021 Updated 10/08/2026 |
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 25021-821-05) | Sagent Pharmaceuticals | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: November 2026, Product on hand is 8-12 months of dating prior to expiry | Posted 12/15/2021 Updated 10/08/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)